首页> 美国卫生研究院文献>Current Neuropharmacology >Recent Advances in the Molecular Pathogenesis of Dystonia-Plus Syndromes and Heredodegenerative Dystonias
【2h】

Recent Advances in the Molecular Pathogenesis of Dystonia-Plus Syndromes and Heredodegenerative Dystonias

机译:肌张力障碍加综合征和遗传退化性肌张力障碍的分子发病机理的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The majority of studies investigating the molecular pathogenesis and cell biology underlying dystonia have been performed in individuals with primary dystonia. This includes monogenic forms such as DYT1and DYT6 dystonia, and primary focal dystonia which is likely to be multifactorial in origin. In recent years there has been renewed interest in non-primary forms of dystonia including the dystonia-plus syndromes and heredodegenerative disorders. These are caused by a variety of genetic mutations and their study has contributed to our understanding of the neuronal dysfunction that leads to dystonia These findings have reinforced themes identified from study of primary dystonia including abnormal dopaminergic signalling, cellular trafficking and mitochondrial function. In this review we highlight recent advances in the understanding of the dystonia-plus syndromes and heredodegenerative dystonias.
机译:调查肌张力障碍的分子发病机制和细胞生物学的大多数研究已在原发性肌张力障碍的个体中进行。这包括单基因形式,例如DYT1和DYT6肌张力障碍和原发性局灶性肌张力障碍,其起源可能是多因素的。近年来,人们对非主要形式的肌张力障碍,包括肌张力障碍加综合症和遗传退化性疾病,重新产生了兴趣。这些是由多种遗传突变引起的,他们的研究有助于我们理解导致肌张力障碍的神经元功能障碍。这些发现加强了原发性肌张力障碍研究中确定的主题,包括多巴胺能信号异常,细胞运输和线粒体功能异常。在这篇综述中,我们重点介绍了对肌张力障碍加综合征和异变性肌张力障碍了解的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号